WP
ABBV icon

Wealthspan Partners’s AbbVie ABBV Stock Holding History

Wealthspan Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$845K Sell
3,359
-15
-0.4% -$3.23K 0.27% 62
2026
Q1 		$734K Buy
3,374
+1
+0% +$222 0.26% 62
2025
Q4 		$771K Buy
3,373
+1
+0% +$228 0.28% 60
2025
Q3 		$781K Sell
3,372
-99
-3% -$20.2K 0.3% 54
2025
Q2 		$644K Sell
3,471
-123
-3% -$22.9K 0.27% 56
2025
Q1 		$753K Sell
3,594
-258
-7% -$50.2K 0.35% 49
2024
Q4 		$685K Buy
3,852
+39
+1% +$7.17K 0.33% 53
2024
Q3 		$753K Hold
3,813
– – 0.37% 51
2024
Q2 		$654K Hold
3,813
– – 0.36% 49
2024
Q1 		$694K Buy
3,813
+144
+4% +$24.8K 0.41% 44
2023
Q4 		$569K Buy
3,669
+271
+8% +$39.5K 0.4% 42
2023
Q3 		$507K Buy
3,398
+1
+0% +$147 0.4% 45
2023
Q2 		$458K Buy
3,397
+6
+0.2% +$880 0.36% 42
2023
Q1 		$540K Sell
3,391
-5
-0.1% -$764 0.46% 41
2022
Q4 		$549K Buy
3,396
+124
+4% +$19K 0.5% 38
2022
Q3 		$439K Buy
3,272
+30
+0.9% +$4.3K 0.45% 40
2022
Q2 		$497K Buy
3,242
+189
+6% +$28.9K 0.51% 36
2022
Q1 		$495K Buy
3,053
+8
+0.3% +$1.16K 0.45% 40
2021
Q4 		$412K Buy
+3,045
New +$360K 0.36% 46

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wealthspan Partners's ABBV Position: Q2 2026 in Review

Wealthspan Partners reduced its AbbVie (ABBV) stake by 0.44% in Q2 2026, selling an estimated $3.23K and leaving 3,359 shares worth $845K. The position accounts for 0.27% of the portfolio, ranked #62.

Wealthspan Partners first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Wealthspan Partners held 3,359 shares of AbbVie worth $845K as of Q2 2026.
  • Wealthspan Partners sold 15 AbbVie shares in Q2 2026, an estimated $3.23K.
  • AbbVie made up 0.27% of Wealthspan Partners's portfolio in Q2 2026, its #62 holding.
  • Wealthspan Partners first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
  • 4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Wealthspan Partners's 13F filing for Q2 2026, filed 6 Aug 2026.